Senescent zombie cells refuse to die and secrete inflammatory factors that accelerate aging and chronic diseases. New therapies called senolytics can eliminate these cells, potentially extending healthy lifespan and preventing conditions from arthritis to neurodegeneration.
Scientists are racing toward longevity escape velocity, where medical advances extend life faster than we age. Senolytics, NAD+ boosters, and stem cell therapies target aging mechanisms, making 150-year lifespans plausible for future generations, but equity and sustainability challenges loom large.
Age-reversal technologies including telomere extension, senolytics, and regenerative medicine are transitioning from labs to trials, promising extended lifespans that could fundamentally reshape economies, healthcare, and society—but raising urgent questions about equity and access.
Senolytic drugs selectively eliminate zombie cells that accumulate with age, showing breakthrough results in human trials for cancer treatment and metabolic health.
Loading featured articles...